Weekly Market Roundup

  • Roundtable Launches Real-Time USDC Ad Payments for Journalists

    Roundtable Launches Real-Time USDC Ad Payments for Journalists

    Ad payments on one media platform can take 90 days or more to reach the people who earned them. Roundtable’s version settles in USDC in real time. The next day, the Federal Reserve proposed its first rules for the companies that issue stablecoins. Roundtable Launches USDC Ad Payments for Journalists With Coinbase Roundtable (Nasdaq: RTB)…

    read more

  • newcleo Raises $247 Million in SPAC Merger, Starts Trading on Nasdaq

    newcleo Raises $247 Million in SPAC Merger, Starts Trading on Nasdaq

    newcleo plans to fuel its reactors with recycled nuclear material. The SPAC deal that took it public set a pre-money value of about $2.4 billion. On day one, the stock traded as high as $13.56 and as low as $7.15. Energy Vault had a steadier week. newcleo Closes SPAC Merger, Raises $247 Million, Starts Trading…

    read more

  • Enablence Guides 150% Revenue Growth as Wafer Demand Outpaces Supply

    Enablence Guides 150% Revenue Growth as Wafer Demand Outpaces Supply

    Selling every unit you can produce usually counts as a good problem. For one optical chipmaker, it also meant a full fiscal year of negative gross margins. Enablence now guides next year’s revenue to roughly two and a half times this year’s, and it closed C$25 million four days before saying so. Meanwhile, a quantum…

    read more

  • Longeveron’s HLHS Trial Misses Primary Endpoint, Reviews Options

    Longeveron’s HLHS Trial Misses Primary Endpoint, Reviews Options

    A trial run in China just handed Cue Biopharma a stock chart that spiked more than 40% before giving almost all of it back in the same session. Longeveron’s pediatric heart trial met the opposite fate, missing its main goal just days after the company finally cleared a Nasdaq compliance deadline it had spent a…

    read more

  • A $180 Million Reverse Merger Sends Aethlon Medical Up Nearly 400%, Plus New Copper-Gold Grades in the Yukon

    A $180 Million Reverse Merger Sends Aethlon Medical Up Nearly 400%, Plus New Copper-Gold Grades in the Yukon

    Aethlon Medical told shareholders in June that it might not survive the next twelve months without new financing. In September, its stock gained more in a single premarket session than most small caps move in a year, on news that had nothing to do with anything Aethlon found in its own lab. A Yukon copper…

    read more

  • Trident, Goliath, Abitibi Report Fresh Gold and Copper Assays

    Trident, Goliath, Abitibi Report Fresh Gold and Copper Assays

    Two hundred and twenty meters below workings a mining company walked away from in 1998, a drill bit found some of the best gold grades of the season. A high-grade discovery in British Columbia’s Golden Triangle kept adding visible gold to an already sprawling footprint. A Quebec copper deposit got wider and richer in the…

    read more

  • Senate Fails to Advance CLARITY Act on 49-50 Cloture Vote

    Senate Fails to Advance CLARITY Act on 49-50 Cloture Vote

    A microcap crypto infrastructure company just signed its fourth cooperation agreement with the same partner in under a year. The same week, the U.S. Senate killed the crypto industry’s biggest legislative priority in a single procedural vote. One story is about two small companies building something together. The other is about Washington failing to build…

    read more

  • GMG’s Battery Hits 489 Charge Cycles With No Measurable Performance Loss

    GMG’s Battery Hits 489 Charge Cycles With No Measurable Performance Loss

    A graphene battery cell just ran 489 charge and discharge cycles without losing any measurable performance, verified by an independent US testing lab rather than the company’s own claims. Zoom out from any single stock this week and the broader data tells its own story: US solar capacity just crossed a real threshold, enough installed…

    read more

  • Tecsys Beats Q1 Estimates, Raises Guidance, Plus Another Big Quantum Move

    Tecsys Beats Q1 Estimates, Raises Guidance, Plus Another Big Quantum Move

    Tecsys posted a profit surprise of roughly 91% versus what analysts expected, and the stock still needed a full day to catch up. In California, the federal government agreed to take an equity stake in a publicly traded quantum computing company as a condition of writing it a $100 million check, the kind of arrangement…

    read more

  • Tenon Medical Surges on Debt Repayment, Negative Equity Remains

    Tenon Medical Surges on Debt Repayment, Negative Equity Remains

    A $5 million debt payment doubled Tenon Medical’s stock price in two days. The company had negative equity going into that payment. AEON Biopharma spent the same stretch adding another data point to a multi-year case that its botulinum toxin candidate matches BOTOX at the molecular level. Neither story ends with an approved product yet,…

    read more